99
Views
0
CrossRef citations to date
0
Altmetric
Review

Investigating the unmet need for the treatment of tricuspid regurgitation

ORCID Icon &
Pages 397-407 | Received 26 Dec 2022, Accepted 03 May 2023, Published online: 08 May 2023

References

  • Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10;63(22):e57–185. doi:10.1016/j.jacc.2014.02.536.
  • Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019 Mar;12(3):433–442. doi:10.1016/j.jcmg.2018.06.014.
  • Hahn RT, Waxman AB, Denti P, et al. Anatomic relationship of the complex tricuspid valve, right ventricle, and pulmonary vasculature: a review. JAMA Cardiol. 2019 May 1;4(5):478–487. doi:10.1001/jamacardio.2019.0535.
  • Praz F, Muraru D, Kreidel F, et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021 Nov 19;17(10):791–808. doi:10.4244/EIJ-D-21-00695
  • Chorin E, Rozenbaum Z, Topilsky Y, et al. Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):157–165. PMID: 31544933. doi:10.1093/ehjci/jez216.
  • Benfari G, Antoine C, Miller WL, et al. Excess Mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019 Jul 16;140(3):196–206. doi:10.1161/CIRCULATIONAHA.118.038946
  • Latib A. Transcatheter tricuspid valve intervention: addressing an unmet clinical need. Interv Cardiol Clin. 2018 Jan;7(1):8–14. doi:10.1016/j.iccl.2017.10.001.
  • Sun BJ, Park JH. Current unmet needs and clues to the solution in the management of tricuspid regurgitation. Korean Circ J. 2022 Jun;52(6):414–428. doi:10.4070/kcj.2022.0117.
  • Hahn RT, Badano LP, Bartko PE, et al. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. Eur Heart J Cardiovasc ImagingEur Heart J Cardiovasc Imaging. 2022 Jun 212022 Oct 13;23(7):913–929. Erratum in PMID: 35157070. doi: 10.1093/ehjci/jeac009.
  • Hahn RT, Weckbach LT, Noack T, et al. Proposal for a standard echocardiographic tricuspid valve nomenclature. JACC Cardiovasc Imaging. 2021 Jul;14(7):1299–1305. doi:10.1016/j.jcmg.2021.01.012.
  • Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: sCOUT trial 30-day results. J Am Coll Cardiol. 2017 Apr 11;69(14):1795–1806. doi:10.1016/j.jacc.2017.01.054.
  • Alipour Symakani RS, Bartelds B, Merkus D, et al. Guiding interventions for secondary tricuspid regurgitation: follow the intricate interplay between form and function. Cardiol Rev. 2023 Jan 1;31(1):7–15. doi:10.1097/CRD.0000000000000415.
  • Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017 Dec 19;70(24):2953–2960. doi:10.1016/j.jacc.2017.10.039.
  • Hamandi M, Smith RL, Ryan WH, et al. Outcomes of isolated tricuspid valve surgery have improved in the modern era. Ann Thorac Surg. 2019 Jul;108(1):11–15. doi:10.1016/j.athoracsur.2019.03.004.
  • Staab ME, Nishimura RA, Dearani JA. Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: analysis of outcome in 34 patients. J Heart Valve Dis. 1999 Sep;8(5):567–574.
  • McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004 Mar;127(3):674–685. doi:10.1016/j.jtcvs.2003.11.019.
  • Sala A, Lorusso R, Bargagna M, et al. Isolated tricuspid valve surgery: first outcomes report according to a novel clinical and functional staging of tricuspid regurgitation. Eur J Cardiothorac Surg. 2021 Nov 2;60(5):1124–1130. doi:10.1093/ejcts/ezab228.
  • Sala A, Lorusso R, Zancanaro E, et al. Mid-term outcomes of isolated tricuspid valve surgery according to preoperative clinical and functional staging. Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac172. doi:10.1093/ejcts/ezac172.
  • Weiss T, Villadsen PR, Jensen JK, et al. Outcomes of isolated tricuspid valve surgery in contemporary practice. Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac077. doi:10.1093/ejcts/ezac077.
  • Sala A, Beneduce A, Maisano F. Transcatheter and surgical treatment of tricuspid regurgitation: predicting right ventricular decompensation and favorable responders. Front Cardiovasc Med. 2022 Sep 27;9:980639. doi: 10.3389/fcvm.2022.980639.
  • Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2021;43(7):561–632.
  • Bapat V, Tang GHL. Emerging transcatheter options for tricuspid regurgitation: many shades of gray. J Thorac Cardiovasc Surg. 2020 Dec;160(6):1460–1464. doi:10.1016/j.jtcvs.2020.01.102.
  • N FAM. Current devices – are they fit for the task? Presented at: PCR London Valve, London, England, 2022.
  • Overtchouk P, Piazza N, Granada J, et al. Advances in transcatheter mitral and tricuspid therapies. BMC Cardiovasc Disord. 2020 Jan 7;20(1):1. doi:10.1186/s12872-019-01312-3.
  • Sorajja P, Whisenant B, Hamid N, et al. TRILUMINATE pivotal investigators. transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023 Mar 4. doi:10.1056/NEJMoa2300525
  • Gray WA, Abramson SV, Lim S, et al. Cardioband TR EFS investigators. 1-year outcomes of cardioband tricuspid valve reconstruction system early feasibility study. JACC: Cardiovasc Interv. 2022 Oct 10;15(19):1921–1932. doi:10.1016/j.jcin.2022.07.006.
  • Lauten A, Figulla HR, Unbehaun A, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv. 2018 Feb;11(2):e006061. doi:10.1161/CIRCINTERVENTIONS.117.006061.
  • Íñiguez-Romo A, Baz JA, Calvo-Iglesias FE, et al. Percutaneous tricuspid valve replacement using a valved bioprosthesis. Rev Esp Cardiol (Engl Ed). 2019 Dec;72(12):1083–1084. doi:10.1016/j.recesp.2018.12.010. English, Spanish.
  • Lurz P Real-world outcomes for tricuspid edge-to-edge repair: initial one-year outcomes from the bRIGHT trial. Presented at: PCR London Valve, London, England, 2022.
  • Greenbaum A Transcatheter treatment of tricuspid regurgitation: one-year results of the CLASP TR study. Presented at: ACC, Washington, DC, 2022.
  • Young MY Transcatheter tricuspid valve repair: the CLASP II TR trial roll-in cohort. Presented at: PCR London Valve, London, England, 2022.
  • Rudolph V Transcatheter tricuspid annular reduction: the TriBAND study one-year outcomes. Presented at: PCR London Valve, London, Englan, 2022.
  • Nickenig G, Weber M, Schüler R, et al. Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention. 2021 Feb 5;16(15):e1264–1271. doi:10.4244/EIJ-D-20-01107
  • Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, et al. 6-month outcomes of the tricvalve system in patients with tricuspid regurgitation: the TRICUS EURO study. JACC: Cardiovasc Interv. 2022 Jul 11;15(13):1366–1377. doi:10.1016/j.jcin.2022.05.022.
  • Wild MG, Lubos E, Cruz-Gonzalez I, et al. Early clinical experience with the TRICENTO bicaval valved stent for treatment of symptomatic severe tricuspid regurgitation: a multicenter registry. Circ Cardiovasc Interv. 2022 Mar;15(3):e011302. doi:10.1161/CIRCINTERVENTIONS.121.011302.
  • Windecker S TRISCEND study one-year outcomes: transfemoral transcatheter tricuspid valve replacement. Presented at: PCR London Valves, London, England, 2022.
  • Modine T Transcatheter tricuspid valve replacement with the Lux-Valve system one-year results of a multicentre, first-in-man experience. Presented at: PCR London Valves, London, England, 2022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.